NCT00964431已完成2 期
A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Indomethacin Test Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 203
- 试验地点
- 1
- 主要终点
- Total Patient Pain Relief Over 0 to 8 Hours.
研究概览
简要总结
The purpose of this study is to determine whether Indomethacin Test Formulation Capsules are safe and effective for the treatment of dental pain.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient is male or female between 18 and 50 years of age
- •For women of child-bearing potential: a woman who is not pregnant and not nursing, and who is practicing an acceptable method of birth control
- •Patient requires extraction of 2 or more third molars
- •Patient must be willing to stay at the study site for at least 8 hours after dosing of the study drug
排除标准
- •Patient has hypersensitivity, allergy, or clinically significant intolerance to any medications to be used in the study, or related drugs
- •Patient has a current disease or history of a disease that will impact the study or the patient's well-being
- •Patient has used or intends to use any of the medications that are prohibited by the protocol
- •Patient has a history of drug or alcohol abuse or dependence, or patient has a positive urine drug screen or alcohol breathalyzer test
- •Patient has taken another investigational drug within 30 days prior to Screening
研究组 & 干预措施
Indomethacin Test (lower dose)
Experimental
干预措施: Indomethacin Test (lower dose) (Drug)
Indomethacin Test (upper dose)
Experimental
Single dose
干预措施: Indomethacin Test (upper dose) (Drug)
Celecoxib 400 mg
Active Comparator
干预措施: Celecoxib 400 mg (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Total Patient Pain Relief Over 0 to 8 Hours.
时间窗: 8 hours
Total patient pain relief was assessed as a time-weighted sum of the patient pain assessments at each individual time point from 0-8 hours. Values for TOTPAR are measured from 0 to 4 on the Pain Relief Scale 0 None Min; 1 A little; 2 Some; 3 A lot; 4 Complete Max The TOTPAR is a weighted measure of the observations; the minimum possible value is 0 and the maximum possible value is 32.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Study of Indomethacin Capsules to Treat Pain Following BunionectomyOther Acute Postoperative PainNCT01543685Iroko Pharmaceuticals, LLC462
已完成
3 期
Study of Indomethacin Capsules to Treat Pain Following BunionectomyOther Acute Postoperative PainNCT01626118Iroko Pharmaceuticals, LLC373
已完成
2 期
Study of Diclofenac Capsules to Treat Dental PainDental PainNCT00985439Iroko Pharmaceuticals, LLC202
已完成
2 期
Study of Naproxen Capsules to Treat Dental PainDental PainNCT01229228Iroko Pharmaceuticals, LLC254
已完成
2 期
MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)SchizophreniaParanoid SchizophreniaNCT00482430Merck Sharp & Dohme LLC50